Ameriprise’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Buy |
945,125
+905,053
| +2,259% | +$10.2M | ﹤0.01% | 1762 |
|
|
2025
Q1 | $462K | Sell |
40,072
-13,310
| -25% | -$154K | ﹤0.01% | 3488 |
|
|
2024
Q4 | $452K | Buy |
+53,382
| New | +$452K | ﹤0.01% | 3533 |
|
|
2023
Q2 | – | Sell |
-13,131
| Closed | -$103K | – | 3953 |
|
|
2023
Q1 | $103K | Buy |
+13,131
| New | +$103K | ﹤0.01% | 3821 |
|